{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:09:05Z","timestamp":1776272945458,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"4","funder":[{"name":"Mid and South Essex NHS Foundation Trust","award":["805109"],"award-info":[{"award-number":["805109"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>A patient presented with progressive lower limb weakness, sensory disturbance and bladder and bowel dysfunction, initially raising concern for cauda equina syndrome. Lumbar MRI excluded compressive pathology, and further imaging revealed a long-segment thoracic cord T2 hyperintensity suggestive of transverse myelitis (TM). Cerebrospinal fluid analysis supported an inflammatory cause. CT imaging identified mediastinal and supraclavicular lymphadenopathy, and lymph node biopsy confirmed non-necrotising granulomatous lymphadenitis, consistent with sarcoidosis. The diagnosis was TM secondary to neurosarcoidosis. High-dose corticosteroids and physiotherapy were initiated, followed by infliximab as a steroid-sparing agent. Follow-up demonstrated radiological improvement and functional gains, though mild deficits persisted. This case highlights the importance of rapidly distinguishing between compressive and non-compressive spinal cord syndromes, the need for systematic investigation of inflammatory myelopathies, and the role of multidisciplinary management in neurosarcoidosis.<\/jats:p>","DOI":"10.1136\/bcr-2025-270083","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:25:18Z","timestamp":1776270318000},"page":"e270083","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Transverse myelitis as an initial presentation of sarcoidosis"],"prefix":"10.1136","volume":"19","author":[{"given":"Vania","family":"Santos","sequence":"first","affiliation":[{"name":"Medical Education, Mid and South Essex NHS Foundation Trust, Basildon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Movio","sequence":"additional","affiliation":[{"name":"Mid and South Essex NHS Foundation Trust, Basildon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Mohan","sequence":"additional","affiliation":[{"name":"Mid and South Essex NHS Foundation Trust, Basildon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"McLellan","sequence":"additional","affiliation":[{"name":"Mid and South Essex NHS Foundation Trust, Basildon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026041509250993000_19.4.e270083.1","first-page":"167","article-title":"Transverse myelitis--a review of the presentation, diagnosis, and initial management","volume":"16","author":"West","year":"2013","journal-title":"Discov Med"},{"key":"2026041509250993000_19.4.e270083.2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00415-016-8336-4","article-title":"Neurosarcoidosis: a clinical approach to diagnosis and management","volume":"264","author":"Ibitoye","year":"2017","journal-title":"J Neurol"},{"key":"2026041509250993000_19.4.e270083.3","first-page":"e1479","article-title":"Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up","volume":"98","author":"Gavoille","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2026041509250993000_19.4.e270083.4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12028-017-0459-7","article-title":"Emergency Neurologic Life Support: Spinal Cord Compression","volume":"27","author":"O\u2019Phelan","year":"2017","journal-title":"Neurocrit Care"},{"key":"2026041509250993000_19.4.e270083.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1516539"},{"key":"2026041509250993000_19.4.e270083.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2021.08.009"},{"key":"2026041509250993000_19.4.e270083.7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2026041509250993000_19.4.e270083.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1"},{"key":"2026041509250993000_19.4.e270083.9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.crad.2016.05.020","article-title":"Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists","volume":"71","author":"Mirbagheri","year":"2016","journal-title":"Clin Radiol"},{"key":"2026041509250993000_19.4.e270083.10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msard.2016.04.005","article-title":"Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction","volume":"9","author":"Kister","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"2026041509250993000_19.4.e270083.11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11882-023-01092-z","article-title":"Neurosarcoidosis: Diagnostic Challenges and Mimics A Review","volume":"23","author":"Shen","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026041509250993000_19.4.e270083.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2026041509250993000_19.4.e270083.13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000847","article-title":"Infliximab treatment in pathology-confirmed neurosarcoidosis","volume":"7","author":"Fritz","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026041509250993000_19.4.e270083.14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/ene.15295","article-title":"Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature","volume":"29","author":"Nolte","year":"2022","journal-title":"Eur J Neurol"},{"key":"2026041509250993000_19.4.e270083.15","unstructured":"BMJ Best Practice . Ransverse myelitis \u2013 epidemiology. BMJ Publishing Group; 2025. Available: https:\/\/bestpractice.bmj.com\/topics\/en-gb\/1061\/epidemiology"},{"key":"2026041509250993000_19.4.e270083.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.05.018"},{"key":"2026041509250993000_19.4.e270083.17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/WNL.0b013e31823dc535","article-title":"Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: [RETIRED]","volume":"77","author":"Scott","year":"2011","journal-title":"Neurology (ECronicon)"},{"key":"2026041509250993000_19.4.e270083.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714"},{"key":"2026041509250993000_19.4.e270083.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7"},{"key":"2026041509250993000_19.4.e270083.20","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-25305"},{"key":"2026041509250993000_19.4.e270083.21","first-page":"121","article-title":"Autoimmune myelopathies","volume":"21","author":"Flanagan","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"2026041509250993000_19.4.e270083.22","doi-asserted-by":"publisher","DOI":"10.2741\/1351"},{"key":"2026041509250993000_19.4.e270083.23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0032-1322588","article-title":"Infectious causes of myelopathy","volume":"32","author":"Ho","year":"2012","journal-title":"Semin Neurol"},{"key":"2026041509250993000_19.4.e270083.24","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0741-x"},{"key":"2026041509250993000_19.4.e270083.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.05.020","article-title":"Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis","volume":"285","author":"Bridel","year":"2015","journal-title":"J Neuroimmunol"},{"key":"2026041509250993000_19.4.e270083.26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1135392","article-title":"Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction","volume":"14","author":"Vlad","year":"2023","journal-title":"Front Neurol"},{"key":"2026041509250993000_19.4.e270083.27","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000725","article-title":"Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis","volume":"7","author":"Otto","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026041509250993000_19.4.e270083.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00805-1"},{"key":"2026041509250993000_19.4.e270083.29","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic utility of serum ACE levels in sarcoidosis: a population-based study","volume":"194","author":"Ungprasert","year":"2016","journal-title":"Lung"},{"key":"2026041509250993000_19.4.e270083.30","doi-asserted-by":"crossref","unstructured":"Keijsers RG , et al . In Which Patients with Sarcoidosis Is FDG PET\/CT Indicated? J Clin Med 2020;9. doi:10.3390\/jcm9030890","DOI":"10.3390\/jcm9030890"},{"key":"2026041509250993000_19.4.e270083.31","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214348"},{"key":"2026041509250993000_19.4.e270083.32","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/acn3.70200","article-title":"A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions","volume":"12","author":"Manzano","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"2026041509250993000_19.4.e270083.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1099"},{"key":"2026041509250993000_19.4.e270083.34","doi-asserted-by":"crossref","unstructured":"Sinha T , Tahir S , Namal FNU , et al . Neurosarcoidosis: Current Perspectives on Diagnosis, Management, and Future Directions. Cureus 2024;19. doi:10.7759\/cureus.69208","DOI":"10.7759\/cureus.69208"},{"key":"2026041509250993000_19.4.e270083.35","unstructured":"British thoracic society . BTS clinical statement on pulmonary sarcoidosis. BTS; 2020. Available: https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-statements\/sarcoidosis\/bts-sarcoidosis-clinical-statement\/"},{"key":"2026041509250993000_19.4.e270083.36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/acn3.51968","article-title":"Infliximab in neurosarcoidosis: a systematic review and meta\u2010analysis","volume":"11","author":"Chaiyanarm","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"2026041509250993000_19.4.e270083.37","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.149989"},{"key":"2026041509250993000_19.4.e270083.38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.545413","article-title":"Treatment of Sarcoidosis: A Multidisciplinary Approach","volume":"11","author":"Gerke","year":"2020","journal-title":"Front Immunol"},{"key":"2026041509250993000_19.4.e270083.39","unstructured":"National Institute for Health and Care Excellence (NICE) . Pulmonary sarcoidosis: infliximab. Evidence summary. NICE; 2016. Available: https:\/\/www.nice.org.uk\/advice\/es2\/chapter\/key-points-from-the-evidence"},{"key":"2026041509250993000_19.4.e270083.40","doi-asserted-by":"crossref","DOI":"10.5334\/jbsr.3479","article-title":"Sarcoidosis Presenting as Longitudinally Extensive Transverse Myelitis: A Case Report","volume":"108","author":"Touri","year":"2024","journal-title":"J Belg Soc Radiol"},{"key":"2026041509250993000_19.4.e270083.41","article-title":"Neurosarcoidosis and Transverse Myelitis: Life-Threatening Manifestations of Sarcoidosis","volume":"16","author":"Patel","year":"2024","journal-title":"Cureus"},{"key":"2026041509250993000_19.4.e270083.42","article-title":"Teaching NeuroImages: Sarcoidosis presenting as longitudinally extensive myelitis\u2014excellent response to infliximab","volume":"81","author":"Goenka","year":"2013","journal-title":"Neurology (ECronicon)"},{"key":"2026041509250993000_19.4.e270083.43","article-title":"Longitudinally Extensive Transverse Myelitis as a First Manifestation of Sarcoidosis","volume":"15","author":"Rodrigues","year":"2023","journal-title":"Cureus"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-270083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:25:24Z","timestamp":1776270324000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-270083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bcr-2025-270083"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-270083","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}